This is a preview of subscription content, log in via an institution to check access.
References
Darby, G., Field, H. J., Salisbury, S. A. Altered substrate specificity of herpes simplex virus thymidine-kinase confers acyclovir resistance. Nature 289 (1981) 81–83.
Furman, P. A., Coen, D. M., St. Clair, M. H., Schaffer, P. A. Acyclovir resistant mutants of herpes simplex virus type 1 express altered DNA polymerase or reduced acyclovir phosphorylating activities. J. Vir. 40 (1981) 936–941.
Chatis, P. A., Crumpacker, C. S. Resistance of herpes viruses to antiviral drugs. Antimicrob. Agents Chemother. 36 (1992) 1589–1595.
Biron, K. K., Fyfe, J. A., Noblin, J. E., Elion, G. B. Selection and preliminary characterization of acyclovir resistant mutants of varicella zoster virus. Am. J. Med. 77 (Suppl. 1A) (1982) 383–386.
Birch, C. J., Tachedjian, G., Doherty, R. R., Hayes, K., Gust, I. D. Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome. J. Infect. Dis. 162 (1990) 731–734.
Walmsley, S. L., Chew, E., Read, S. E., Vellend, H., Salit, I., Rachlis, A., Fanning, M. M. Treatment of cytomegalovirus with trisodium phosphonoformate hexahydrate (foscarnet). J. Infect. Dis. 137 (1988) 569–572.
Safrin, S., Crumpacker, C., Chatis, P., David, R., Hafner, R., Rush, J., Kessler, H. A., Landry, B., Mills, J. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. N. Engl. J. Med. 325 (1991) 551–555.
Fletcher, C. V., Englund, J. A., Bean, B., Chinnock, B., Brundage, D. M., Balfour, H. H. Continuous infusion of high dose acyclovir for serious herpes virus infections. Antimicrob. Agents Chemother. 33 (1989) 1375–1378.
Engel, J. P., Englund, J. A., Fletcher, C. V., Hill, E. L. Treatment of resistant herpes simplex virus with continuous infusion acyclovir. JAMA 263 (1990) 1662–1664.
Spector, S. A., Hintz, M., Wyborny, C., Connor, J. D., Keeny, R. E., Lianos, S. Treatment of herpes virus infections in immunocompromised patients with acyclovir by continuous infusion. Am. J. Med. 73 (Suppl. 1A) (1982) 275–280.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mock, L., Dossou-Gbété, L., Merle-Melet, M. et al. Continuous infusion of acyclovir is more effective than discontinuous infusion for treatment of genital herpes in an immunocompromised patient. Infection 22, 290 (1994). https://doi.org/10.1007/BF01739921
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01739921